Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 59

    Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore

    Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore

    Medical Dialogues Bureau12 Nov 2019 4:46 PM IST
    As per a recent release by Lupin, the proposed transaction values Kyowa at an enterprise value of JPY 57,361 million (~INR 37,024 million) and will...
    Glenmark gets USFDA nod for generic version of Epiduo gel to treat acute acne

    Glenmark gets USFDA nod for generic version of Epiduo gel to treat acute acne

    Medical Dialogues Bureau12 Nov 2019 12:04 PM IST
    The approval granted to Glenmark Pharmaceuticals Inc by the US Food and Drug Administration is for Adapalene and Benzoyl Peroxide Gel, 0.1 per...
    Mega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 crore

    Mega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 crore

    Medical Dialogues Bureau12 Nov 2019 9:45 AM IST
    Novartis's Sandoz generics business agreed to pay 300 million euros initially, plus a deferred amount not expected to exceed 100 million euros based...
    Government approves 4 medical device parks to cut import bill, production cost

    Government approves 4 medical device parks to cut import bill, production cost

    Farhat Nasim12 Nov 2019 9:30 AM IST
    The four medical device parks will provide the necessary infrastructure, where companies can easily plug and play. This will not only cut import bill...
    Lipocine testosterone drug Tlando fails for the thrid time to get USFDA approval

    Lipocine testosterone drug Tlando fails for the thrid time to get USFDA approval

    Medical Dialogues Bureau12 Nov 2019 9:15 AM IST
    The decision marks the third regulatory setback in over three years for Lipocine's Tlando, which aims to restore normal testosterone levels in men...
    Merck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating Avelumab

    Merck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating Avelumab

    Medical Dialogues Bureau12 Nov 2019 9:00 AM IST
    New Delhi: EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. recently announced...
    Wockhardt Q2 net loss widens to Rs 94 cr

    Wockhardt Q2 net loss widens to Rs 94 cr

    Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
    New Delhi: Pharma major Wockhardt on Thursday reported widening of consolidated net loss to Rs 94.24 crore for the September quarter. The company had...
    Glenmark recalls over 2 lakh cartons of product in US

    Glenmark recalls over 2 lakh cartons of product in US

    Medical Dialogues Bureau11 Nov 2019 1:11 PM IST
    NEW DELHI: Drug maker Glenmark Pharmaceuticals is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty...
    RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

    RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

    Medical Dialogues Bureau11 Nov 2019 9:15 AM IST
    The drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Farhat Nasim10 Nov 2019 10:00 AM IST
    New Delhi: Drug firm, Laurus Labs Ltd. recently said in a filing that the US health regulator has issued two observations after the inspection of its...
    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities

    Medical Dialogues Bureau10 Nov 2019 9:45 AM IST
    Aurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
    Sun Pharma reports net profit of Rs 1064 crore in Q2

    Sun Pharma reports net profit of Rs 1064 crore in Q2

    Medical Dialogues Bureau10 Nov 2019 9:30 AM IST
    Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, said Sun...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok